Company news
Shanghai Serum Bio-technology Co., Ltd. Class A (SSE:688163) news
Shanghai Serum Bio-technology Co., Ltd. Class A news releases on 6ix. Latest, Jan 17, 2024: Announcement on Voluntary Disclosure of Ethical Review Approval…
Press releases — page 2
Announcement on Voluntary Disclosure of Ethical Review Approval for Phase II Clinical Trial of Antivenom Serum against Viper Venom
January 16, 2024
Announcement on Resolutions of 1st Special Shareholders' Meeting of 2023
December 18, 2023
Announcement on Resolutions of 17th Session of 3rd Board of Directors
December 1, 2023
Announcement on Convening 2023 3rd Quarter Performance Meeting
November 14, 2023
Announcement on Releasing Detention of One of Actual Controllers and Chairman
October 29, 2023
3rd Quarter Report of 2023
October 27, 2023
Announcement on Expiry of Term of Office of Independent Directors and Postponement of Election of Independent Directors
September 20, 2023
Announcement on Convening 2023 Semi-annual Performance Meeting
September 8, 2023
Announcement on Circulation of Some Restricted Shares in Initial Public Offering
September 1, 2023
Announcement on Resolutions of 11th Session of 3rd Board of Supervisors
August 28, 2023